Answers are grounded in this paper and cite their sources.
Validates MyHPVscore for detecting HPV+ oropharynx cancer, suggesting its effectiveness as a diagnostic tool.
> 0.99). Analytes were stable for 96 hours at -20°C and yielded consistent qualitative results after >400 days of storage. No cross-reactivity was observed between hrHPV types or low-risk types (HPV6, HPV11). These results support the use of MyHPVscore as an LDT for detecting HPV+ oropharynx cancer. This methodology establishes an approach and standard controls that can benchmark other emerging ctDNA assays.
No takes yet. Share an insight, caveat, or question.
Currie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: